Major Players - TCV Vaccines Industry

Over the projected period, the increasing prevalence of typhoid is likely to fuel growth in the worldwide typhoid conjugate vaccines (TCV) market. Public organizations such as the World Health Organization (WHO), Gavi, the Bill and Melinda Gates Foundation, and others are very active in raising awareness about diseases like typhoid and driving immunization efforts against such diseases, which is expected to drive growth in the typhoid conjugate vaccines (TCV) market. Limitations associated with existing vaccinations include lower or no immunogenicity in younger children and babies, a three-year length of protection for polysaccharide vaccine and a seven-year duration of protection for oral live vaccine, which, in turn, requiring recurrent doses and other vaccine delivery platforms, short period of protection (three-five years), and effectiveness only in individuals over two years old have limited adoption of these vaccines to some extent, restricting market growth.

According to Coherent Market Insights, The global TCV Vaccines Market is estimated to be valued at US$ 332.6 million in 2022, and is expected to exhibit a CAGR of 12.1% over the forecast period (2022-2030).

Key Competitors in the TCV Vaccines Industry:

GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Sanofi SA

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. Sanofi was founded in 1973 and is headquartered in Paris, France.

Bharat Biotech

Bharat Biotech International Limited, a biotechnology company, engages in the research, development, and manufacture of vaccines and bio therapeutics. The company was founded in 1996, headquartered in Andhra Pradesh, India.

PT BIO FARMA

Supported by competence and experience for more than 125 years of learning, they are here as part of the struggle to protect and increase the quality of human life. Founded in 1890, headquartered in Indonesia.

PaxVax, Inc

PaxVax is a vaccine start-up company developing candidate oral vaccines for influenza, and key infectious diseases. It has developed a proprietary oral vaccine technology based on a common virus called adenovirus. The technology removes the delivery hurdles of traditional injectable vaccines, namely the need for cold storage, needles, and Administration by medical personnel. PaxVax was founded in 2007 and is headquartered in Gaithersburg, Maryland.

*Definition-

Nutritional supplements are food items that meet nutritional needs caused by physical or physiological conditions, as well as specific illnesses and disorders.